★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerCommoditiesEconomics & TradeMonetary Policy Central Banks Embark on a Gold Buying Spree as Instability Threatens to Spark a Rally Though gold has skidded into its worst losing streak in more than 150 years, central bank buying has accelerated to…McAlinden Research PartnersNovember 2, 2022
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerCommoditiesEnergy & EnvironmentPolitics & Policy Biden Launches Renewed Windfall Tax Threat, Yet Congressional Support Remains Uncertain Windfall taxes on the energy industry are once again being floated by lawmakers in the US, just ahead of key…McAlinden Research PartnersNovember 1, 2022
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerEconomics & TradeⓁ Aerospace & DefenseManufacturing & LogisticsPolitics & Policy Defense Sector Earnings, Developments in Ukraine Detail Significant Upside for Weapons and Equipment Sales Q3 earnings figures in the US aerospace and defense industry were broadly positive, pushing up valuations across the sector throughout…McAlinden Research PartnersOctober 31, 2022
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerEnergy & EnvironmentPolitics & Policy Solar Power Faces Surging Inflation Threat, US Cost Cutting Measures Could Dull its Impact Solar costs, which have fallen almost non-stop for the past decade, are at risk of reversing course due to persistent…McAlinden Research PartnersOctober 26, 2022
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerCommoditiesEconomics & TradeEnergy & EnvironmentⓁ Saudi ArabiaPolitics & Policy Rising Oil Revenues Help Saudi Arabia Accelerate Economic Transformation via Vision 2030 Saudi Arabia is utilizing surging oil revenues to accelerate the transformation of its economy through the Vision 2030 initiative. The…McAlinden Research PartnersOctober 25, 2022
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerBiotechnology & HealthcareⓁ Gene EditingⓁ PharmaceuticalsMarkets Pharma Fires Up More M&A Deals in Genetic Medicine as First CRISPR Drug Moves Closer to Commercialization Mergers and Acquisitions in the biopharma space continue to heat up, fueling a significant increase in large deals through the first 9…McAlinden Research PartnersOctober 19, 2022
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerCommoditiesEconomics & TradePolitics & Policy OPEC+ Overshoots Expectations with New Output Cuts, American Oil & Gas Revival Becomes Critical OPEC+ delivered a shock to oil markets last week. The syndicate drove WTI benchmark crude to its highest close since…McAlinden Research PartnersOctober 10, 2022
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerⓁ CybersecurityPolitics & PolicyTechnology Cybersecurity Firms Are Fending off a Tsunami of Dangerous DDoS Attacks A surge in cyberattacks continues to gain steam in 2022. This trend is especially pronounced in the number of distributed denial…McAlinden Research PartnersOctober 5, 2022
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerCommoditiesEnergy & EnvironmentPolitics & Policy Oil Prices Bounce as OPEC+ Plans Production Cuts and Asserts Energy Market Dominance Energy stocks posted their best day in two years yesterday, emerging from a September slump. That was largely a reaction…McAlinden Research PartnersOctober 4, 2022
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerBiotechnology & HealthcareⓁ Gene EditingMarkets CRISPR Tech Closes in on First FDA Approval, New Treatment Methods Continue to Emerge The US's first marketed CRISPR drug may be set to make its debut in a year or less, following CRISPR…McAlinden Research PartnersSeptember 29, 2022